Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.

Yuhong Peng; Xianghua Fu; Wei Li; Wei Geng; Kun Xing; Leisheng Ru; Jiaan Sun; Yuying Zhao

首页> 外文期刊>Coronary artery disease >Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.

【24h】

Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.

机译：冠脉内山coronary碱和地尔硫卓在初次经皮冠状动脉介入治疗对急性心肌梗死的影响。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Intracoronary anisodamine and diltiazem administration before stenting improved the angiographic results and prevented reperfusion arrhythmia in patients with STEMI undergoing PCI.

机译：支架置入术前使用冠脉内山an碱和地尔硫卓可改善STEMI患者行PCI的血管造影结果，并防止再灌注性心律不齐。

著录项

来源
《Coronary artery disease》 |2014年第8期|共8页
作者
Yuhong Peng; Xianghua Fu; Wei Li; Wei Geng; Kun Xing; Leisheng Ru; Jiaan Sun; Yuying Zhao;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction. [J] . Yuhong Peng, Xianghua Fu, Wei Li, Coronary artery disease . 2014,第8期

机译：冠脉内山coronary碱和地尔硫卓在初次经皮冠状动脉介入治疗对急性心肌梗死的影响。
2. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction [J] . FU Xiang-hua, XUE Ling, FAN Wei-ze, 中华医学杂志（英文版） . 2007,第014期

机译：冠脉内注射山iso碱对急性心肌梗死患者初次经皮冠状动脉介入治疗后慢回流现象的影响
3. Intracoronary administration of different doses of anisodamine in primary percutaneous coronary intervention: protective effect in patients with ST-segment elevation myocardial infarction [J] . Bai Shiru, Fu Xianghua, Gu Xinshun, Coronary artery disease . 2016,第4期

机译：不同剂量山administration碱在原发性经皮冠状动脉介入治疗中的冠状动脉内给药：对ST段抬高型心肌梗死患者的保护作用
4. Immersive and Non-Immersive VR Percutaneous Coronary Intervention Simulation for Acute Myocardial Infarction [C] . Byron Perez-Gutierrez, Alvaro Uribe-Quevedo, Lizeth Vega-Medina, IEEE International Conference on Serious Games and Applications for Health . 2020

机译：沉浸式和非浸入式VR经皮冠状动脉介入治疗急性心肌梗死的模拟
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial [O] . CHUNHONG CHEN, XIANGHUA FU, WEI LI, -1

机译：对急性下下部心肌梗死行初次经皮冠状动脉介入治疗的个体进行冠脉内山iso碱和尼可地尔的治疗
7. GW25-e4279 Effect of Intracoronary Anisodamine and Diltiazem Administration during Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction [O] . Yuhong Peng, L Wei, Geng Wei, 2014

机译：GW25-e4279急性心肌梗死初次经皮冠状动脉介入治疗期间冠脉内山iso碱和地尔硫卓的应用

Effect of intracoronary anisodamine and diltiazem administration during primary percutaneous coronary intervention in acute myocardial infarction.

摘要

著录项

相似文献

相关主题

期刊订阅